Office of the Director, National Institutes of Health; Notice of Meeting, 22464-22465 [2023-07757]
Download as PDF
22464
Federal Register / Vol. 88, No. 71 / Thursday, April 13, 2023 / Notices
Participation is welcome from
stakeholder communities.
RSVP: Persons seeking to speak at the
listening session must register by
Wednesday, June 14, 2023. Persons
seeking to attend the listening session in
a listen-only capacity must RSVP by
Thursday, June 13, 2023.
Registrants must include their full
name, email address, and organization,
if any, and indicate whether they are
registering as a listen-only attendee or as
a speaker participant to OGA.RSVP1@
hhs.gov.
Requests to participate as a speaker
must include all of the following:
1. The name and email address of the
person desiring to participate
2. The organization(s) that person
represents, if any
3. Identification of the primary article(s)
of interest
Other Information: This listening
session will be recorded for the benefit
of the members of the US Working
Group on Amendments to the IHR
(2005).
Written comments should be emailed
to OGA.RSVP1@hhs.gov with the subject
line ‘‘Written Comment Re: Stakeholder
Listening Session 2 for the IHR’’ by
Friday, June 30, 2023.
We look forward to your comments on
proposed amendments to the
International Health Regulations (2005).
Susan Kim,
Chief of Staff, Office of Global Affairs.
[FR Doc. 2023–07812 Filed 4–12–23; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Global Affairs: Stakeholder
Listening Session for the
Intergovernmental Negotiating Body
(INB) To Draft and Negotiate a WHO
Convention, Agreement or Other
International Instrument on Pandemic
Prevention, Preparedness and
Response
Notice of public listening
session; request for comments.
ACTION:
The listening session will be
held on Wednesday, June 28, 2023, from
12 p.m. to 2 p.m., Eastern Daylight
Time.
Place: The session will be held
virtually, with online and dial-in
information shared with registered
participants.
Status: This meeting is open to the
public but requires RSVP to
OGA.RSVP@hhs.gov by Friday, June 23,
2023. See RSVP section below for
details.
lotter on DSK11XQN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
17:56 Apr 12, 2023
Jkt 259001
SUPPLEMENTARY INFORMATION:
Purpose: The U.S. Department of
Health and Human Services (HHS) and
the Department of State are charged
with co-leading the U.S. delegation to
the Intergovernmental Negotiating Body
to draft and negotiate a WHO
convention, agreement or other
international instrument on pandemic
prevention, preparedness and response
and will convene an informal
Stakeholder Listening Session.
The Stakeholder Listening Session is
designed to seek input from
stakeholders and subject matter experts
to help inform and prepare for U.S.
government engagement with the
Intergovernmental Negotiating Body.
Matters to be Discussed: The listening
session will discuss potential areas that
could be included in a pandemic accord
to promote pandemic prevention,
preparedness, and response. Topics will
include those found in the current draft
of the Pandemic Accord. More
information can be found at: https://
apps.who.int/gb/inb/.
Participation is welcome from all
stakeholder communities.
RSVP: Persons seeking to speak at the
listening session must register by
Friday, June 23, 2023. Persons seeking
to attend the listening session in a
listen-only capacity must register by
Monday, June 26, 2023.
Registrants must include their full
name, email address, and organization,
if any, and indicate whether they are
registering as a listen-only attendee or as
a speaker participant to OGA.RSVP@
hhs.gov.
Requests to participate as a speaker
must include all of the following:
1. The name and email address of the
person desiring to participate
2. The organization(s) that person
represents, if any
3. Identification of the primary topic of
interest
Other Information: This listening
session will be recorded for the benefit
of the members of the US Government
who participate in the
Intergovernmental Negotiating Body.
Written comments should be emailed
to OGA.RSVP@hhs.gov with the subject
line ‘‘Written Comment Re: Stakeholder
Listening Session 2 for the INB’’ by
Friday, July 7, 2023.
We look forward to your comments on
the Intergovernmental Negotiating Body
(INB) and Draft of the WHO convention,
agreement or other international
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
instrument on pandemic prevention,
preparedness and response.
Susan Kim,
Chief of Staff, Office of Global Affairs.
[FR Doc. 2023–07810 Filed 4–12–23; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Council of Councils.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Council of Councils.
Date: May 11, 2023.
Open: 10:15 a.m. to 2:00 p.m.
Agenda: Call to Order and Introductions;
Announcements; NIH Program Updates;
Strategic Plans; and Other Business of the
Committee.
Place: National Institutes of Health,
Building 1, 1 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health,
Building 1, 1 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Council of
Councils, Director, Office of Research
Infrastructure Programs, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda,
MD 20892, GriederF@mail.nih.gov, 301–435–
0744.
Any interested person may file written
comments with the committee by forwarding
E:\FR\FM\13APN1.SGM
13APN1
Federal Register / Vol. 88, No. 71 / Thursday, April 13, 2023 / Notices
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: April 7, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07757 Filed 4–12–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 408–
9465, moscajos@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 7, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07754 Filed 4–12–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
0361.
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Biomedical Research.
Date: May 11, 2023.
Time: 10:00 a.m. to 9:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph D. Mosca, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
To carry out OMB Circular A–102 1
and 2 CFR part 215.51 2, SAMHSA must
collect grant program information
necessary to ensure compliance with
Federal and programmatic
requirements. The Generic Clearance for
1 Circular A–102: https://www.whitehouse.gov/
wp-content/uploads/legacy_drupal_files/omb/
circulars/A102/a102.pdf.
2 2 CFR part 215.51: https://www.govinfo.gov/
content/pkg/CFR-2012-title2-vol1/pdf/CFR-2012title2-vol1-subtitleA.pdf.
VerDate Sep<11>2014
17:56 Apr 12, 2023
Jkt 259001
Project: Generic Clearance for Grant
Program Monitoring Activities
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
22465
Grant Program Monitoring Activities
allows SAMHSA to collect standardized
information from its grant recipients
necessary to perform agency program
oversight activities such as monitoring
progress on recipient activities and
determining and responding to
recipient’s training and technical
assistance (T/TA) needs. SAMHSA
currently manages grant programs that
provide prevention, treatment, recovery
support services, and T/TA for
substance use treatment and mental
health providers along the continuum of
care including prevention, harm
reduction, treatment, and recovery.
SAMHSA’s grant recipients are
currently required to submit various
types of performance reports in
accordance with their individual
program requirements. The data
collections will be designed to
standardize program monitoring and
performance reports of SAMHSA’s
grants. Program offices will use
information collected under this generic
clearance to monitor funding recipient
activities and to provide support or take
appropriate action, as needed.
A generic clearance would provide
SAMHSA’s program offices the
flexibility to create and use tailored
information collection templates based
on current program reporting
requirements. This is important to allow
for SAMHSA’s:
• Monitoring of compliance with
federal practice, guidelines, and
requirements,
• Oversight of the implementation of
the scope of the grant activities with the
grant recipients’ proposed project,
• Assessment of the efficiency and
efficacy of recipient activities,
• Quick understanding of and
remediation to national, regional, and/or
site-specific issues,
• Provision of additional support and
technical assistance, as needed,
• Documentation of promising
practices, innovative services, and
program strengths, and
• Flexible and responsive oversight of
federal funds.
A variety of performance reports will
be used for collection. Program offices
will use information collected under
this generic clearance to monitor
funding recipient activities and to
provide support or take appropriate
action, as needed.
A variety of instruments and
platforms will be used to collect
information from respondents. The
annual burden hours requested
E:\FR\FM\13APN1.SGM
13APN1
Agencies
[Federal Register Volume 88, Number 71 (Thursday, April 13, 2023)]
[Notices]
[Pages 22464-22465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07757]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Council of
Councils.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to attend and need
special assistance, such as sign language interpretation or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The open session will be videocast and
can be accessed from the NIH Videocasting and Podcasting website
(https://videocast.nih.gov).
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Date: May 11, 2023.
Open: 10:15 a.m. to 2:00 p.m.
Agenda: Call to Order and Introductions; Announcements; NIH
Program Updates; Strategic Plans; and Other Business of the
Committee.
Place: National Institutes of Health, Building 1, 1 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, Building 1, 1 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Franziska Grieder, D.V.M., Ph.D., Executive
Secretary, Council of Councils, Director, Office of Research
Infrastructure Programs, Division of Program Coordination, Planning,
and Strategic Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda, MD 20892,
[email protected], 301-435-0744.
Any interested person may file written comments with the
committee by forwarding
[[Page 22465]]
the statement to the Contact Person listed on this notice. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Information is also available on the Council of Council's home
page at https://dpcpsi.nih.gov/council/ where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: April 7, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07757 Filed 4-12-23; 8:45 am]
BILLING CODE 4140-01-P